Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024

ビタミンD療法の世界市場予測(~2024年)

◆タイトル:Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
◆商品コード:PH-7060
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年4月29日
◆ページ数:77
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ビタミンD療法の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、投与経路別(経口、非経口)分析、年齢層別(子ども、大人、シニア)分析、購入パターン別(OTC、処方薬)分析、用途別(骨粗しょう症、くる病、自己免疫疾患、皮膚病)分析、ビタミンD療法の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Vitamin D therapy market to register a CAGR of 11.6% from 2019 to 2024.”
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency, growing focus on healthy diets among consumers, and the presence of a large target patient population. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. On the other hand, the fortification of foods is likely to challenge market growth to a certain extent.

“Oral route of administration accounted for a significant share of the market, by route of administration, in 2018.”
By route of administration, the vitamin D therapy market is segmented into oral and parenteral routes of administration. In 2018, the oral route of administration accounted for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. This is mainly due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, and a higher preference for the oral route.

“By purchasing pattern, prescription drugs held the largest share of the vitamin D therapy market in 2018.”
On the basis of purchasing pattern, the vitamin D therapy market is segmented into OTC and prescription drugs. In 2018, the prescription drugs segment accounted for the largest share of the vitamin D therapy market. The large share of this segment can be attributed to the fact that vitamin D deficiency is mostly diagnosed by registered medical practitioners that provide prescriptions for appropriate medications.

“Asia Pacific dominated the vitamin D therapy market in 2018.”
The Asia Pacific, which includes China, Japan, India, and the Rest of Asia Pacific, accounted for the largest share of the vitamin D therapy market. The large share of this market segment can be attributed to the increasing awareness about vitamin D deficiency and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, atypical diets, decreasing sun exposure, and rising malnutrition levels.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 – 20%, Tier 2 – 45%, and Tier 3 – 35%
• By Designation: C-level – 30%, Director-level – 20%, and Others – 50%
• By Region: North America – 35%, Europe – 24%, Asia Pacific – 25%, and RoW – 16%

Research Coverage
This report studies the vitamin D therapy market by route of administration, application, age group, purchasing pattern, and region. The report also analyzes factors such as drivers, opportunities, and challenges affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vitamin D therapy market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on vitamin D offered by the top 10 players in the vitamin D therapy market. The report analyzes the market by route of administration, application, age group, purchasing pattern, and region
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various vitamin D supplements across key geographic regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin D therapy market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the vitamin D therapy market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.2.1 MARKETS COVERED 14
1.2.2 YEARS CONSIDERED FOR THE STUDY 14
1.3 CURRENCY 15
1.4 LIMITATIONS 15
1.5 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 SECONDARY DATA 17
2.1.1 KEY DATA FROM SECONDARY SOURCES 17
2.2 PRIMARY DATA 18
2.2.1 KEY DATA FROM PRIMARY SOURCES 18
2.3 MARKET SIZE ESTIMATION 19
2.3.1 BOTTOM-UP APPROACH 19
2.3.2 TOP-DOWN APPROACH 20
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.5 ASSUMPTIONS FOR THE STUDY 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 27
4.1 VITAMIN D: MARKET OVERVIEW 27
4.2 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION (2019) 28
4.3 GEOGRAPHICAL SNAPSHOT OF THE VITAMIN D THERAPY MARKET 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
5.2.1 DRIVERS 31
5.2.1.1 Growing awareness about vitamin d deficiency among consumers 31
5.2.1.2 Presence of a large target patient population 31
5.2.2 MARKET OPPORTUNITIES 32
5.2.2.1 Growth opportunities in countries with a high prevalence of undernutrition 32
5.2.3 MARKET CHALLENGES 32
5.2.3.1 Fortified foods 32
6 ROLE OF VITAMIN D IN DISEASE PROGRESSION 33
6.1 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CANCER 33
6.2 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF DIABETES 33
6.3 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES 34
7 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION 35
7.1 INTRODUCTION 36
7.2 ORAL ROUTE OF ADMINISTRATION 36
7.2.1 ORAL ROUTE OF ADMINISTRATION LIKELY TO DOMINATE THE VITAMIN D THERAPY MARKET DUE TO HIGH PATIENT COMPLIANCE 36
7.3 PARENTERAL ROUTE OF ADMINISTRATION 37
7.3.1 USE OF PARENTERALS IS MOSTLY RESERVED FOR HYPOVITAMINOSIS D 37
8 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN 39
8.1 INTRODUCTION 40
8.2 PRESCRIPTION DRUGS 40
8.2.1 GROWING HYPOVITAMINOSIS D PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET 40
8.3 OVER-THE-COUNTER DRUGS 41
8.3.1 EASE OF PURCHASE LEADS TO PEOPLE OPTING FOR OTC 41
9 VITAMIN D THERAPY MARKET, BY APPLICATION 42
9.1 INTRODUCTION 43
9.2 OSTEOPOROSIS 43
9.2.1 FRACTURES AND BROKEN BONES LEADING TO RISE IN VITAMIN D THERAPY MARKET 43
9.3 RICKETS 44
9.3.1 UPDATED GUIDELINES ON DAILY DIETARY INTAKE OF VITAMIN D LIKELY TO LOWER INCIDENCE OF RICKETS 44
9.4 MUSCLE WEAKNESS 45
9.4.1 EVIDENCE INDICATES IMPACT OF VITAMIN D ON ATHLETE AND INJURY PROFILES 45
9.5 AUTOIMMUNE DISORDERS 46
9.5.1 RESEARCH IS REQUIRED TO UNDERSTAND THE ROLE OF VITAMIN D IN AUTOIMMUNE DISORDERS 46
9.6 SKIN DISEASES 47
9.6.1 IMMUNOMODULATORY ACTIVITY OF VITAMIN D LIKELY TO INCREASE THE MARKET FOR PSORIASIS 47
9.7 OTHER APPLICATIONS 48

10 VITAMIN D THERAPY MARKET, BY AGE GROUP 49
10.1 INTRODUCTION 50
10.2 SENIOR ADULTS 50
10.2.1 INCREASING INCIDENCE OF OSTEOPOROSIS AMONG SENIOR ADULTS HAS DRIVEN DEMAND FOR VITAMIN D 50
10.3 ADULTS 51
10.3.1 SEDENTARY LIFESTYLES ARE LEADING TO HYPOVITAMINOSIS D AMONG ADULTS 51
10.4 CHILDREN 52
10.4.1 HIGH PREVALENCE OF RICKETS AMONG CHILDREN IS DRIVING MARKET GROWTH 52
11 VITAMIN D THERAPY MARKET, BY REGION 53
11.1 INTRODUCTION 54
11.2 NORTH AMERICA 54
11.2.1 US 58
11.2.1.1 US to dominate the North American vitamin D therapy market 58
11.2.2 CANADA 60
11.2.2.1 Limited endogenous synthesis and limited dietary sources are the major factors responsible for vitamin D deficiency in the Canadian population 60
11.3 EUROPE 62
11.3.1 UK 64
11.3.1.1 Vitamin D deficiency is prevalent among all age groups in the UK 64
11.3.2 GERMANY 66
11.3.2.1 High prevalence of osteoporosis is expected to be the key factor driving market growth in Germany 66
11.3.3 FRANCE 68
11.3.3.1 Vitamin D levels are declining in France 68
11.3.4 REST OF EUROPE 70
11.4 ASIA PACIFIC 72
11.4.1 CHINA 75
11.4.1.1 Heavy air pollution and sedentary lifestyles are driving market growth in China 75
11.4.2 JAPAN 77
11.4.2.1 Increasing incidence of vitamin D deficiency in Japan to drive market growth 77
11.4.3 INDIA 79
11.4.3.1 A large part of India’s population is vitamin D-deficient 79
11.4.4 REST OF ASIA PACIFIC 81
11.5 REST OF THE WORLD 83

12 COMPETITIVE LANDSCAPE 85
12.1 OVERVIEW 85
12.2 MARKET RANKING ANALYSIS, 2018 85
12.3 KEY STRATEGIES 86
12.3.1 ACQUISITIONS AND COLLABORATIONS, 2015–2018 86
12.4 COMPETITIVE LEADERSHIP MAPPING (2018) 86
12.4.1 VISIONARY LEADERS 87
12.4.2 INNOVATORS 87
12.4.3 DYNAMIC DIFFERENTIATORS 87
12.4.4 EMERGING COMPANIES 87
13 COMPANY PROFILES 89
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 NOVARTIS AG 89
13.2 PFIZER INC 91
13.3 GLAXOSMITHKLINE PLC 93
13.4 MERCK & CO., INC. 95
13.5 ABBOTT 97
13.6 SANOFI 99
13.7 TORRENT PHARMACEUTICALS LTD. 100
13.8 SUN PHARMACEUTICAL INDUSTRIES LTD. 102
13.9 ALKEM LABORATORIES LTD. 103
13.10 CADILA HEALTHCARE LTD. 104

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 106
14.1 INSIGHTS OF INDUSTRY EXPERTS 106
14.2 DISCUSSION GUIDE 107
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 109
14.4 AVAILABLE CUSTOMIZATIONS 111
14.5 RELATED REPORTS 111
14.6 AUTHOR DETAILS 112

LIST OF TABLES

TABLE 1 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 36
TABLE 2 VITAMIN D THERAPY MARKET FOR ORAL ROUTE OF ADMINISTRATION,
BY REGION, 2017–2024 (USD MILLION) 37
TABLE 3 VITAMIN D THERAPY MARKET FOR PARENTERAL ROUTE OF ADMINISTRATION,
BY REGION, 2017–2024 (USD MILLION) 38
TABLE 4 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 40
TABLE 5 VITAMIN D THERAPY MARKET FOR PRESCRIPTION DRUGS,
BY REGION, 2017–2024 (USD MILLION) 40
TABLE 6 VITAMIN D THERAPY MARKET FOR OTC DRUGS, BY REGION,
2017–2024 (USD MILLION) 41
TABLE 7 VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 43
TABLE 8 VITAMIN D THERAPY MARKET FOR OSTEOPOROSIS, BY REGION,
2017–2024 (USD MILLION) 44
TABLE 9 VITAMIN D THERAPY MARKET FOR RICKETS, BY REGION,
2017–2024 (USD MILLION) 45
TABLE 10 VITAMIN D THERAPY MARKET FOR MUSCLE WEAKNESS,
BY REGION, 2017–2024 (USD MILLION) 46
TABLE 11 VITAMIN D THERAPY MARKET FOR AUTOIMMUNE DISORDERS,
BY REGION, 2017–2024 (USD MILLION) 47
TABLE 12 VITAMIN D THERAPY MARKET FOR SKIN DISEASES, BY REGION,
2017–2024 (USD MILLION) 47
TABLE 13 VITAMIN D THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 48
TABLE 14 VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 50
TABLE 15 VITAMIN D THERAPY MARKET FOR SENIOR ADULTS, BY REGION,
2017–2024 (USD MILLION) 51
TABLE 16 VITAMIN D THERAPY MARKET FOR ADULTS, BY REGION,
2017–2024 (USD MILLION) 51
TABLE 17 VITAMIN D THERAPY MARKET FOR CHILDREN, BY REGION,
2017–2024 (USD MILLION) 52
TABLE 18 VITAMIN D THERAPY MARKET, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 19 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 56
TABLE 20 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION) 56
TABLE 21 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION) 56
TABLE 22 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 57
TABLE 23 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY AGE GROUP,
2017–2024 (USD MILLION) 57
TABLE 24 US: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 58
TABLE 25 US: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 58
TABLE 26 US: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 59
TABLE 27 US: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 59
TABLE 28 CANADA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 60
TABLE 29 CANADA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 60
TABLE 30 CANADA: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 61
TABLE 31 CANADA: VITAMIN D THERAPY MARKET, BY AGE GROUP,
2017–2024 (USD MILLION) 61
TABLE 32 EUROPE: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 33 EUROPE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 62
TABLE 34 EUROPE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 63
TABLE 35 EUROPE: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 63
TABLE 36 EUROPE: VITAMIN D THERAPY MARKET, BY AGE GROUP,
2017–2024 (USD MILLION) 63
TABLE 37 UK: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 64
TABLE 38 UK: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 65
TABLE 39 UK: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 65
TABLE 40 UK: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 65
TABLE 41 GERMANY: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 66
TABLE 42 GERMANY: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 66
TABLE 43 GERMANY: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 67
TABLE 44 GERMANY: VITAMIN D THERAPY MARKET, BY AGE GROUP,
2017–2024 (USD MILLION) 67
TABLE 45 FRANCE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 68
TABLE 46 FRANCE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 68
TABLE 47 FRANCE: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 69
TABLE 48 FRANCE: VITAMIN D THERAPY MARKET, BY AGE GROUP,
2017–2024 (USD MILLION) 69
TABLE 49 ROE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 70
TABLE 50 ROE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 70
TABLE 51 ROE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 71
TABLE 52 ROE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 71
TABLE 53 APAC: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 73
TABLE 54 APAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 73
TABLE 55 APAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 73
TABLE 56 APAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 74
TABLE 57 APAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 74
TABLE 58 CHINA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 75
TABLE 59 CHINA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 75
TABLE 60 CHINA: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 76
TABLE 61 CHINA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 76
TABLE 62 JAPAN: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 77
TABLE 63 JAPAN: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 77
TABLE 64 JAPAN: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 78
TABLE 65 JAPAN: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 78
TABLE 66 INDIA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 79
TABLE 67 INDIA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 79
TABLE 68 INDIA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 80
TABLE 69 INDIA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 80
TABLE 70 ROAPAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 81
TABLE 71 ROAPAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 81
TABLE 72 ROAPAC: VITAMIN D THERAPY MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 82
TABLE 73 ROAPAC: VITAMIN D THERAPY MARKET, BY AGE GROUP,
2017–2024 (USD MILLION) 82
TABLE 74 ROW: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2017–2024 (USD MILLION) 83
TABLE 75 ROW: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2017–2024 (USD MILLION) 83
TABLE 76 ROW: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 84
TABLE 77 ROW: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION) 84


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 16
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 18
FIGURE 3 VITAMIN D THERAPY MARKET: BOTTOM-UP APPROACH 19
FIGURE 4 VITAMIN D THERAPY MARKET: TOP-DOWN APPROACH 20
FIGURE 5 DATA TRIANGULATION METHODOLOGY 21
FIGURE 6 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION,
2019 VS. 2024 (USD MILLION) 23
FIGURE 7 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN,
2019 VS. 2024 (USD MILLION) 24
FIGURE 8 VITAMIN D THERAPY MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 24
FIGURE 9 VITAMIN D THERAPY MARKET, BY AGE GROUP, 2019 VS. 2024 (USD MILLION) 25
FIGURE 10 VITAMIN D THERAPY MARKET, BY REGION, 2019 VS. 2024 (USD MILLION) 25
FIGURE 11 GROWING AWARENESS ABOUT VITAMIN D DEFICIENCY AND LARGE PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 27
FIGURE 12 ORAL ROUTE OF ADMINISTRATION TO DOMINATE THE NORTH AMERICAN VITAMIN D THERAPY MARKET IN 2019 28
FIGURE 13 ASIAN COUNTRIES TO REGISTER HIGH GROWTH RATES DURING THE FORECAST PERIOD 29
FIGURE 14 VITAMIN D THERAPY MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 30
FIGURE 15 NORTH AMERICA: VITAMIN D THERAPY MARKET SNAPSHOT 55
FIGURE 16 ASIA PACIFIC: VITAMIN D THERAPY MARKET SNAPSHOT 72
FIGURE 17 KEY DEVELOPMENTS IN THE VITAMIN D THERAPY MARKET FROM 2015 TO 2018 85
FIGURE 18 VITAMIN D THERAPY MARKET RANKING, BY KEY PLAYER, 2018 85
FIGURE 19 MNM DIVE-VENDOR COMPARISON MATRIX: VITAMIN D THERAPY MARKET 88
FIGURE 20 NOVARTIS AG: COMPANY SNAPSHOT (2018) 89
FIGURE 21 PFIZER INC.: COMPANY SNAPSHOT (2018) 91
FIGURE 22 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2018) 93
FIGURE 23 MERCK & CO., INC.: COMPANY SNAPSHOT (2018) 95
FIGURE 24 ABBOTT: COMPANY SNAPSHOT (2018) 97
FIGURE 25 SANOFI: COMPANY SNAPSHOT 99
FIGURE 26 TORRENT: COMPANY SNAPSHOT (2018) 100
FIGURE 27 SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2018) 102
FIGURE 28 ALKEM LABORATORIES LTD.: COMPANY SNAPSHOT (2018) 103
FIGURE 29 CADILA HEALTHCARE LTD.: COMPANY SNAPSHOT (2018) 104


★調査レポート[ビタミンD療法の世界市場予測(~2024年)] ( Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024 / PH-7060) 販売に関する免責事項
[ビタミンD療法の世界市場予測(~2024年)] ( Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024 / PH-7060) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆